Jake Bauer - May 1, 2025 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Christopher Van Tuyl, Attorney-in-Fact for Jacob Bauer
Stock symbol
IMVT
Transactions as of
May 1, 2025
Transactions value $
$0
Form type
4
Date filed
5/5/2025, 07:30 PM
Previous filing
Apr 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bauer Jake Director C/O IMMUNOVANT, INC., 320 WEST 37TH STREET, 6TH FLOOR, NEW YORK /s/ Christopher Van Tuyl, Attorney-in-Fact for Jacob Bauer 2025-05-05 0001654909

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +25K $0.00 25K May 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (Right to Buy) Award $0 +35.2K $0.00 35.2K May 1, 2025 Common Stock 35.2K $15.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in three equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date.
F2 These options were granted pursuant to the Plan. The shares underlying the options will vest in three equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date.